Anteris Technologies Global Corp. (AVR) Stock Forecast Oct. 13, 2026
Analysis updated on Oct. 13, 2026 (UTC) · Alpha · vs marketSwitch to Total · Nasdaq
Anteris Technologies Global Corp. (AVR) stock forecast summary
Our AI ranks Anteris Technologies Global Corp. outside the neutral middle of its coverage (a directional signal). Create a free account and follow it to see the exact price target.
Anteris Technologies Global Corp. is a small-cap company with a market capitalization of $629M. It ranks number 10 by market capitalization among the 24 Orthopedic, Prosthetic & Surgical Appliances & Supplies issuers in our coverage with a current forecast. Its D/E Ratio of 0.08x is the lowest of the 23 peers that report one.
A per-ticker accuracy statistic for AVR is published only once its sample size is known. Across our coverage, the out-of-sample test on 4537 stocks from 2025-01-06 to 2026-06-09 produced a positive net return in 73.7% of rebalance periods (factor-neutral book, net of estimated costs). Full backtest report
Expected return relative to the market over the horizon: a positive alpha means the model expects the stock to beat the market, whatever the market does. Ratings: strong buy ≥ +1.3%, buy ≥ +0.5%, sell < -0.5%, strong sell < -1.6% (top 15%, next 20%, middle 30%, next 20%, bottom 15% of the 2026-10-13 signals)
A free account shows the exact forecast, rating and rank of 3 tickers you follow, AVR included.
Follow AVR freeAVR price chart and AI forecast
How AVR ranks among 5379 stocks
90D Alpha forecasts of every company scored, cut into five relative ratings at the 15th, 35th, 65th and 85th percentiles (dashed lines).
Anteris Technologies Global Corp. (AVR) fundamentals
Trailing twelve months. The industry median and the rank (1 = highest) are taken over the Orthopedic, Prosthetic & Surgical Appliances & Supplies peers listed below that report each metric.
Reported net income does not reconcile with earnings per share and the share count, so net-income-based ratios are withheld.
Valuation & Market
| Metric | AVR | Rank |
|---|---|---|
| Market Cap | $629M | 10/24 |
| P/B Ratio | 2.50x | 11/19 |
| EPS | $-2.27 | – |
| Book Value/Share | $2.58 | – |
| Revenue/Share | $0.02 | – |
| FCF/Share | $-0.91 | – |
Profitability & Margins
| Metric | AVR | Rank |
|---|---|---|
| ROIC | -41.8% | 14/21 |
| Operating Margin | -6077.5% | 20/21 |
| EBT Margin | -5859.0% | 20/21 |
| Tax Rate | -0.5% | – |
Financial Health
| Metric | AVR | Rank |
|---|---|---|
| Current Ratio | 14.20x | 2/24 |
| Quick Ratio | 14.20x | 1/21 |
| D/E Ratio | 0.08x | 23/23 |
| Financial Leverage | 1.08x | 23/23 |
| Interest Coverage | -298.1x | 17/21 |
| Working Capital | $242M | 7/22 |
Cash Flow
| Metric | AVR | Rank |
|---|---|---|
| Operating Cash Flow | -$86M | 22/22 |
| Free Cash Flow | -$88M | 16/16 |
| Capital Spending | -$2M | 8/16 |
| FCF/Sales | -5046.3% | 16/16 |
| CapEx/Sales | 111.8% | 1/16 |
Operational Efficiency
| Metric | AVR | Rank |
|---|---|---|
| Asset Turnover | 0.01x | 18/18 |
| Receivables Turnover | 3.2x | 15/16 |
| Inventory Turnover | 70.1x | 1/21 |
| Fixed Assets Turnover | 0.3x | 17/18 |
| Days Sales Outstanding | 114 days | 2/16 |
| Days Inventory | 5 days | 21/21 |
| Payables Period | 3318 days | 2/18 |
| Cash Conversion Cycle | -3198 days | 14/15 |
Income Statement
| Metric | AVR | Rank |
|---|---|---|
| Total Revenue | $1M | 16/18 |
| Operating Income | -$106M | 21/22 |
| R&D Expense | $77M | 6/19 |
| SG&A Expense | $31M | 12/19 |
| Cost of Goods Sold | $560K | 19/20 |
Dividend & Shareholder Information
| Metric | AVR | Rank |
|---|---|---|
| Shares Outstanding | 97M | – |
Balance Sheet Highlights (USD millions)
| Total Current Assets | $261M | 95.7% of assets |
| Cash & Short-term Investments | $250M | 91.8% of assets |
| Accounts Receivable | $550K | 0.2% of assets |
| Inventory | $10K | 0.0% of assets |
| Total Liabilities | $21M | 7.7% of assets |
| Short-term Debt | $13M | 4.9% of assets |
AVR quarterly financials and insider trading
Anteris Technologies Global Corp. (AVR) industry peers
Companies classified under the same SEC industry code as Anteris Technologies Global Corp. (Orthopedic, Prosthetic & Surgical Appliances & Supplies): 27 common-stock issuers with a forecast this week, one row per issuer, largest first. This is a classification match, not a curated list of competitors.
Reveal all forecasts · See exact % predictions for all competitors
Sign up free| Company | 90-Day AI Forecast (Alpha) | Market Cap |
|---|---|---|
| AVR Anteris Technologies Global Corp. | ▼ | $629M |
| ISRG Intuitive Surgical Inc | ▼ | $149.10B |
| SNN Smith & Nephew Plc | ▼ | $24.29B |
| STE Steris Plc | ▼ | $21.35B |
| ZBH Zimmer Biomet Holdings, Inc. | ▼ | $17.58B |
| ALGN Align Technology Inc | ▼ | $10.20B |
| MSA Msa Safety Inc | ▼ | $7.01B |
| ESTA Establishment Labs Holdings Inc. | ▲ | $1.74B |
| CDRE Cadre Holdings, Inc. | ▶ | $1.12B |
| ENOV Enovis Corp | ▶ | $1.10B |
| SMTI Sanara Medtech Inc. | ▼ | $323M |
| INGN Inogen Inc | ▶ | $168M |
| LAKE Lakeland Industries Inc | ▲ | $97M |
| NTRB Nutriband Inc. | ▲ | $71M |
| APT Alpha Pro Tech Ltd | ▲ | $59M |
| MYO Myomo, Inc. | ▲ | $51M |
| COCH Envoy Medical, Inc. | ▶ | $50M |
| MLSS Milestone Scientific Inc. | ▲ | $31M |
| LFWD Lifeward Ltd. | ▲ | $18M |
| UEEC United Health Products, Inc. | ▶ | $12M |
| RGNT Regentis Biomaterials Ltd. | ▼ | $8M |
| CLGN Collplant Biotechnologies Ltd | ▶ | $5M |
| RBOT Vicarious Surgical Inc. | ▼ | $360K |
| FEED Envue Medical, Inc. | ▼ | $320K |
| BBLG Bone Biologics Corp | ▶ | N/A |
| CUPR Cuprina Holdings (Cayman) Ltd | ▼ | N/A |
| LGMK Logicmark, Inc. | ▼ | N/A |
Where AVR sits on the market map
Anteris Technologies Global Corp. (AVR) stock news
Loading...
Anteris Technologies Global Corp. (AVR) stock forecast FAQ
What is the Anteris Technologies Global Corp. (AVR) stock forecast?
Our AI ranks Anteris Technologies Global Corp. outside the neutral middle of its coverage (a directional signal). Create a free account and follow it to see the exact price target.
How accurate are Anteris Technologies Global Corp. stock predictions?
A per-ticker accuracy statistic for AVR is published only once its sample size is known. Across our coverage, the out-of-sample test on 4537 stocks from 2025-01-06 to 2026-06-09 produced a positive net return in 73.7% of rebalance periods (factor-neutral book, net of estimated costs). Full backtest report
How often are Anteris Technologies Global Corp. forecasts updated?
Anteris Technologies Global Corp. forecasts are refreshed on trading days as the daily model run completes. The forecast on this page was produced on Oct. 13, 2026.
Which companies are Anteris Technologies Global Corp.'s industry peers?
27 issuers in our coverage, AVR included, share the SEC industry code Orthopedic, Prosthetic & Surgical Appliances & Supplies. The largest are: Intuitive Surgical Inc (ISRG), Smith & Nephew Plc (SNN), Steris Plc (STE), Zimmer Biomet Holdings, Inc. (ZBH), Align Technology Inc (ALGN), Msa Safety Inc (MSA).
This analysis is generated automatically using our proprietary AI systems and should not be considered personalized investment advice. Past performance does not guarantee future results. Always conduct your own research and consider consulting a financial advisor before making investment decisions.